Please wait while we load the requested 10-K report or click the link below:
https://last10k.com/sec-filings/report/1042418/000119312519066503/d668655d10k.htm
SEC Filings
HPPI Annual Reports
HPPI Quarterly Reports
HPPI Corporate News
Other Events
Regulated Disclosure July 2019
Event for Officers July 2019
Other Events June 2019
Financial Exhibit
Other Events April 2019
Other Events
Regulated Disclosure February 2019
Event for Officers
Financial Exhibit
New Agreement December 2018
Bylaw Change
Event for Officers
Financial Exhibit
New Agreement
Other Events December 2018
Regulated Disclosure November 2018
Financial Exhibit
Other Events
Unregistered Sales July 2018
Financial Exhibit
New Agreement
Other Events
Unregistered Sales January 2018
Other Events
Regulated Disclosure
Regulated Disclosure
July 2019
Event for Officers
July 2019
Other Events
June 2019
Financial Exhibit
Other Events
Other Events
April 2019
Other Events
Regulated Disclosure
Regulated Disclosure
February 2019
Event for Officers
Financial Exhibit
New Agreement
Financial Exhibit
New Agreement
December 2018
Bylaw Change
Event for Officers
Financial Exhibit
New Agreement
Other Events
Event for Officers
Financial Exhibit
New Agreement
Other Events
December 2018
Regulated Disclosure
November 2018
Financial Exhibit
Other Events
Unregistered Sales
Other Events
Unregistered Sales
July 2018
Financial Exhibit
New Agreement
Other Events
Unregistered Sales
New Agreement
Other Events
Unregistered Sales
January 2018
Last10K.com | 10-K Annual Report Thu Mar 07 2019
Document And Entity Information - USD ($) | 12 Months Ended | ||
|---|---|---|---|
Dec. 31, 2018 | Mar. 07, 2019 | Jun. 30, 2018 | |
| Document Information [Line Items] | |||
| Document Type | 10-K | ||
| Amendment Flag | false | ||
| Document Period End Date | Dec. 31, 2018 | ||
| Document Fiscal Year Focus | 2018 | ||
| Document Fiscal Period Focus | FY | ||
| Entity Registrant Name | HedgePath Pharmaceuticals, Inc. | ||
| Entity Central Index Key | 0001042418 | ||
| Current Fiscal Year End Date | --12-31 | ||
| Trading Symbol | HPPI | ||
| Entity Well-known Seasoned Issuer | No | ||
| Entity Current Reporting Status | Yes | ||
| Entity Voluntary Filers | No | ||
| Entity Filer Category | Non-accelerated Filer | ||
| Entity Shell Company | false | ||
| Entity Emerging Growth Company | false | ||
| Entity Small Business | true | ||
| Entity Common Stock, Shares Outstanding | 370,446,185 | ||
| Entity Public Float | $ 24,879,000 |
View differences made from one year to another to evaluate Hedgepath Pharmaceuticals, Inc.'s financial trajectory
Compare this 10-K Annual Report to its predecessor by reading our highlights to see what text and tables were removed , added and changed by Hedgepath Pharmaceuticals, Inc..
Assess how Hedgepath Pharmaceuticals, Inc.'s management team is paid from their Annual Proxy
Hedgepath Pharmaceuticals, Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2019 10-K Annual Report includes:
- Voting Procedures
- Board Members
- Executive Team
- Salaries, Bonuses, Perks
- Peers / Competitors
SEC Filing Tools
Financial Statements, Disclosures and Schedules
Inside this 10-K Annual Report
Document And Entity Information
Balance Sheets
Balance Sheets (Parenthetical)
Statements Of Cash Flows
Statements Of Operations
Statements Of Stockholders' Equity
Corporate Overview
Corporate Overview - Additional Information (Detail)
Income Taxes
Income Taxes (Tables)
Income Taxes - Additional Information (Detail)
Income Taxes - Components Of Deferred Income Tax Assets And Liabilities (Detail)
Income Taxes - The Difference Between Expected Income Tax Benefits And Income Tax Benefit Recorded In The Financial Statements (Detail)
Legal Proceedings
Liquidity And Management's Plans
Liquidity And Management's Plans - Additional Information (Detail)
Related Party Transactions
Related Party Transactions - Additional Information (Detail)
Stockholders' Equity
Stockholders' Equity (Tables)
Stockholders' Equity - Additional Information (Detail)
Stockholders' Equity - Information Regarding Stock Options Outstanding And Exercisable (Detail)
Stockholders' Equity - Schedule Of Stock Option Activity (Detail)
Stockholders' Equity - Summary Of Non-Vested Stock Option Activity (Detail)
Stockholders' Equity - Summary Of Warrant Exercises (Detail)
Subsequent Events
Subsequent Events - Additional Information (Detail)
Summary Of Significant Accounting Policies
Summary Of Significant Accounting Policies (Policies)
Summary Of Significant Accounting Policies - Additional Information (Detail)
Material Contracts, Statements, Certifications & more
Hedgepath Pharmaceuticals, Inc. provided additional information to their SEC Filing as exhibits
Exhibit 10.5: Material Contract
Exhibit 10.6: Material Contract
Exhibit 10.7: Material Contract
Exhibit 23.1: Consents Of Experts And Counsel
Exhibit 31.1: Rule 13A-14(A)/15D-14(A) Certification
Exhibit 31.2: Rule 13A-14(A)/15D-14(A) Certification
Exhibit 32.1: Section 1350 Certification
Exhibit 32.2: Section 1350 Certification
Ticker: HPPI
CIK: 1042418
Form Type: 10-K Annual Report
Accession Number: 0001193125-19-066503
Submitted to the SEC: Thu Mar 07 2019 9:01:34 AM EST
Accepted by the SEC: Thu Mar 07 2019
Period: Monday, December 31, 2018
Industry: Commercial Physical And Biological Research
External Resources:
Stock Quote
Social Media
Bookmark the Permalink: https://last10k.com/sec-filings/hppi/0001193125-19-066503.htm
SEC Filing Exhibit
PDF Download
Loading SEC Filing Exhibit...
Excel DownloadLoading SEC Filing Financial Summary...